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Translocation of PDK-1 to the plasma membrane is important in
allowing PDK-1 to activate protein kinase B
Karen E. Anderson, John Coadwell, Len R. Stephens and Phillip T. Hawkins
Background: Protein kinase B (PKB) is involved in the regulation of apoptosis,
protein synthesis and glycogen metabolism in mammalian cells.
Phosphoinositide-dependent protein kinase (PDK-1) activates PKB in a manner
dependent on phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3), which
is also needed for the translocation of PKB to the plasma membrane. It has been
proposed that the amount of PKB activated is determined exclusively as a result
of its translocation, and that a constitutively active pool of membrane-associated
PDK-1 simply phosphorylates all the PKB made available. Here, we have
investigated the effects of membrane localisation of PDK-1 on PKB activation.
Results: Ectopically expressed PDK-1 translocated to the plasma membrane in
response to platelet-derived growth factor (PDGF) and translocation was
sensitive to wortmannin, an inhibitor of phosphoinositide 3-kinase. Translocation
of PDK-1 also occurred upon its co-expression with constitutively active
phosphoinositide 3-kinase, but not with an inactive form. Overexpression of
PDK-1 enhanced the ability of PDGF to activate PKB. PDK-1 disrupted in the
pleckstrin homology (PH) domain which did not translocate to the membrane
did not increase PKB activity in response to PDGF, whereas membrane-
targeted PDK-1 activated PKB to the extent that it could not be activated
further by PDGF.
Conclusions: In response to PDGF, binding of PtdIns(3,4,5)P3 and/or
PtdIns(3,4)P2 to the PH domain of PDK-1 causes its translocation to the
plasma membrane where it co-localises with PKB, significantly contributing to
the scale of PKB activation.
Background
Protein kinase B (PKB) [1–3] is a key protein serine/threo-
nine kinase that can be activated by cell-surface receptors
and phosphorylates cellular targets involved in processes
such as apoptosis [4,5], protein synthesis [6] and glycogen
metabolism [7,8]. The activation of PKB appears to be
mediated by type-1 phosphoinositide (PI) 3-kinases and
their lipid products, phosphatidylinositol 3,4,5-trisphos-
phate (PtdIns(3,4,5)P3) and PtdIns(3,4)P2, as inhibitors of
PI 3-kinases and dominant-negative PI 3-kinase constructs
abolish PKB stimulation [6,9], whereas constitutively
active PI 3-kinases directly stimulate PKB activity [10,11]. 
Several distinct events are associated with the activation of
PKB. As a result of binding of the amino-terminal pleck-
strin-homology (PH) domain of PKB to PtdIns(3,4,5)P3 and
PtdIns(3,4)P2 produced upon appropriate receptor activa-
tion, PKB translocates to the plasma membrane [12–14].
PKB is also phosphorylated on Thr308 and Ser473, and this
phosphorylation is dependent on PI 3-kinase [15]. We have
previously used point mutational analysis to show that
phosphorylation of Thr308 is necessary and sufficient for
activation of PKB by platelet-derived growth factor
(PDGF) in porcine aortic endothelial (PAE) cells, as
assessed by kinase activity in vitro, whereas phosphorylation
of Ser473 is not sufficient but is necessary for maximal acti-
vation [13]. Protein kinases dependent on 3-phosphoinosi-
tides and capable of phosphorylating Thr308 of PKB —
PDK-1s — have been purified from muscle [16] and brain
[17], peptide sequenced and cloned [18,19]. Thus far a
single PDK-1 gene has been identified; the various activi-
ties that have been purified might result from differential
splicing of this gene. PDK-1 has been shown to phosphory-
late Thr308 of PKB in vitro but only in the presence of
PtdIns(3,4,5)P3-containing lipid vesicles or detergent
micelles into which PKB can translocate [17,16].
A key issue that remains to be resolved is whether mem-
brane localisation of PKB is sufficient to enable PDK-1 to
phosphorylate Thr308, or whether the 3-phosphorylated
lipids also ‘activate’ PDK-1 (in that they either increase its
intrinsic catalytic activity or its access to substrates). The
fact that PDK-1 contains a carboxy-terminal PH domain
and can bind lipid vesicles containing PtdIns(3,4,5)P3 or
PtdIns(3,4)P2 [18] appears to suggest that 3-phosphory-
lated lipids can ‘activate’ PDK-1 in some way. This
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remains to be clarified, however. Insulin, which increases
the levels of 3-phosphorylated lipids, has been reported to
have no apparent effect on the kinase activity of PDK-1 in
vitro [19]. Furthermore, the concentrations of 3-phospho-
rylated inositol lipids required to translocate PDK-1 to
lipid vesicles are very small [18], such that the concentra-
tions of these lipids in unstimulated cells might be suffi-
cient to localise significant quantities of PDK-1 to the
membrane. Finally, PDK-1 has been shown to phosphory-
late Thr252 of soluble p70S6K, a site analagous to Thr308
of PKB, in a PtdIns(3,4,5)P3-independent manner [20,21].
Here, we have studied the subcellular localisation of
PDK-1 in both unstimulated and PDGF-stimulated PAE
cells, and investigated the effect of the membrane locali-
sation of PDK-1 on the ability of PDGF to activate PKB.
Results
We have previously cloned the PDK-1 gene from a U937
cDNA library as a cDNA with a potential open reading
frame (ORF) encoding a 556 amino acid protein (predicted
size 63 kDa). It is clear from peptide sequencing of puri-
fied protein that this gene locus also gives rise to some
smaller proteins [18]. We do not yet understand the mech-
anism for this, but in the only alternatively spliced tran-
scripts we have discovered so far, the initiation of protein
translation would have to be from internal methionine
codons of the defined sequence (unpublished data). For
the purposes of this study, therefore, as well as using
63 kDa PDK-1, an additional construct was made encoding
a 507 amino acid protein (predicted size 58 kDa) that com-
mences 50 amino acids into the sequence of the 63 kDa
protein at a candidate internal methionine residue. We also
previously identified another ORF in the PDK-1 gene
which is missing an exon encoding part of the kinase
domain; it encodes an apparently catalytically inactive
protein [18]. Mammalian expression vectors encoding
tagged versions of these PDK-1 variants were constructed
and used to investigate the regulation of PDK-1 and PKB
in response to PDGF stimulation.
PDGF induces PDK-1 translocation to the plasma
membrane in a manner dependent on PI 3-kinase
PAE cells were transiently transfected with expression
vectors for 63 kDa PDK-1 tagged at its amino terminus
with the Myc epitope (PDK(63kD)), plated onto cover-
slips for 30 hours and then serum starved for an additional
15 hours. Immunohistochemical analysis of unstimulated
cells revealed a pattern of staining indicative of a cytosolic
distribution for ectopically expressed PDK-1. No nuclear
staining was evident, while only minor levels of staining
were observed on the periphery of the cell (Figure 1a).
Stimulation of cells with the B chain of PDGF
(PDGF-BB) produced a marked alteration in the cellular
distribution of PDK(63kD). Homogenous staining across
the entire cell surface was observed, with a sharply defined
edge to the cells, indicative of plasma membrane localisa-
tion (Figure 1a). This interpretation was confirmed by
confocal microscopy (Figure 2). Thus PDK-1 translocates
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Figure 1
Immunolocalisation of PDK-1 in unstimulated
and PDGF-stimulated PAE cells. PAE cells
were transiently transfected with 20 µg of the
vector for either (a) PDK(63kD) (b) myc-
tagged 58 kDa PDK-1 (PDK(58kD)) or 
(c) a version of PDK(63kD) containing a point
mutation in its PH domain (PDK(R474A)),
described in Materials and methods.
Transfected cells (2 × 106) were plated onto
glass coverslips for 30 h then serum-starved
for 15 h (control). Where indicated, cells were
stimulated with PDGF-BB (10 ng/ml, 5 min)
following a 10 min 100 nM wortmannin
pretreatment as appropriate. Cells were
processed for immunohistochemistry as
described in Materials and methods using
anti-Myc 9E10 monoclonal antibody as a
primary antibody and FITC-conjugated goat
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to the plasma membrane in response to PDGF stimula-
tion. This PDGF-induced translocation was dependent on
PI 3-kinase, as it was inhibited by pretreatment of cells
with wortmannin (100 nM) for 10 minutes (Figure 1a).
PAE cells were also transfected with a vector encoding a
Myc-tagged 58 kDa form of PDK-1 (PDK(58kD)), which
showed a similar PI-3-kinase-dependent, PDGF-induced
translocation to the plasma membrane (Figure 1b).
To further investigate the involvement of PI 3-kinase and
its lipid products in the observed translocation of PDK-1,
Cos-7 cells were transiently co-transfected with the vector
encoding PDK(63kD) and vectors for either a constitu-
tively active p110γ PI 3-kinase catalytic subunit (p110*) or
a ‘kinase-dead’ version (p110-KD). Plasma membrane
translocation of PDK(63kD) was observed upon co-
expression with the active PI 3-kinase, but not the kinase-
dead version (Figure 3), indicating direct involvement of
the lipid products of PI 3-kinase in the translocation
process. Parallel experiments using a catalytically inactive
version of PDK-1 demonstrated that it would also translo-
cate to the plasma membrane when co-transfected with
p110* but not p110-KD (data not shown). Thus, PDK-1
translocates to the plasma membrane in response to acti-
vated PI 3-kinase and this response does not depend on
the catalytic activity of PDK-1. Studies were performed to
determine the effects of this observed translocation on the
ability of PDK-1 to enhance PDGF-induced PKB activity. 
PDK-1 potentiates PDGF-stimulated PKB activity
PAE cells were transfected with plasmids encoding
PDK(63kD) or PDK(58kD) and a glutamine (EE)-tagged
phosphorylation site mutant of PKB (PKB(S473D)), in
which the amino acid substitution mimics phosphorylation
at residue Ser473 of PKB [15]. As phosphorylation of both
Thr308 and Ser473 of PKB is critical for maximal PKB
activity [13,15] and, furthermore, PDK-1 is known to phos-
phorylate Thr308 exclusively [16,17], we used PKB(S473D)
to investigate the effects of Thr308 phosphorylation of PKB
by PDK-1 in isolation. PKB(S473D) was found to have the
same immunolocalisation as wild-type PKB and to respond
similarly to co-expression with PDK-1, under both control
and PDGF-stimulated conditions (data not shown). Trans-
fected PAE cells were incubated for 12 hours, then serum
starved for 11 hours. Cells were briefly stimulated with a
submaximal dose of PDGF (2 ng/ml for 45 seconds), to
ensure that the scale of the response we were analysing was
not limited by these parameters.
The anti-EE-immunoprecipitated PKB activity in PAE
cells expressing PKB(S473D) in the absence of PDK-1
was low and increased with submaximal PDGF stimula-
tion (Figure 4a). Co-expression of PDK(63kD) and
PKB(S473D) resulted in a rise in basal PKB activity, as
well as a dramatic increase in PDGF-stimulated PKB
activity (Figure 4a). Expression of PDK-1 resulted in
PDGF eliciting a fivefold greater increase in EE-associ-
ated PKB activity than in cells transfected with an irrele-
vant cDNA. Similar potentiation of PDGF-stimulated
PKB activity occurred with co-transfection of PDK(58kD)
(Figure 4a). The potentiation of PKB activity by PDK-1
was dependent on PI 3-kinase, being abolished by pre-
treatment of the cells with wortmannin (Figure 5).
Expression of either PDK(58kD) or PDK(63kD) did not
affect the level of co-expressed PKB(S473D) in PAE cells
(data not shown). The observed PDGF-stimulated
translocation of either 63 kDa or 58 kDa PDK-1 to the
plasma membrane therefore appears to be associated with
the ability of PDK-1 to enhance PKB activity. The two
variants of PDK-1 used in this study, PDK(58kD) and
Figure 2
Confocal images of PDK-1 immunolocalisation in unstimulated and
PDGF-stimulated PAE cells. PAE cells were transiently transfected with
20 µg of the vector for PDK(63kD) as described in Materials and
methods. Cells were grown, stimulated with PDGF, and processed for





PDK-1 translocation in the presence of active PI 3-kinase. Cos-7 cells
were transiently cotransfected with 10 µg of the vector for PDK(63kD)
and 10 µg of plasmid encoding either a constitutively active p110γ PI
3-kinase catalytic subunit (p110*) or a ‘kinase-dead’ version
(p110-KD), as described in Materials and methods. Cells were
incubated for 20 h, replated onto glass coverslips for 12 h, then serum
starved for 12 h. Cells were processed for immunohistochemistry as
described for Figure 1.
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PDK(63kD), appear to behave in a similar manner,
translocating to the plasma membrane and potentiating
PKB activity in response to PDGF stimulation.
The PH domain of PDK-1 mediates its PI-3-kinase-
dependent translocation and activation of PKB
Given the observed PI 3-kinase dependence of the translo-
cation of PDK-1 in response to PDGF, the ability of PDK-
1 to bind PtdIns(3,4,5)P3 with high affinity in vitro [18], and
its possession of a potentially lipid-binding carboxy-termi-
nal PH domain, experiments were performed to investigate
the involvement of the PH domain of PDK-1 in its PDGF-
stimulated translocation. For these purposes, point muta-
tion of the Arg474 of PDK(63kD) to alanine (R474A) was
performed. This arginine residue in the PH domain of
PDK(63kD), is also found in an analogous position in the
PH domains of both phospholipase C-δ (PLC-δ) and Bru-
ton’s tyrosine kinase (Btk), and has been shown to be criti-
cal in both PLC-δ [22] and Btk [23] for ligand recognition,
and in PLC-δ for membrane association [22]. Furthermore,
this residue is found to be mutated in Btk in patients suf-
fering from agammaglobulinaemia and in mice carrying an
X-linked immunodeficiency [23].
Immunohistochemical analysis of PAE cells transiently
transfected with Myc-tagged R474A PDK-1
(PDK(R474A)) demonstrated similar cytosolic staining
under basal conditions as seen for wild-type PDK(63kD)
(Figure 1). In marked contrast to wild-type PDK(63kD),
however, PDGF stimulation of the cells expressing
PDK(R474A), while producing significant cellular ruffling,
did not induce a significant change in the localisation of
PDK(R474A) (Figure 1c).
The ability of PDK(R474A) to stimulate the PDGF-
induced activity of co-expressed PKB(S473D) in PAE
cells was low in comparison to that of PDK(63kD)
(Figure 4a). Western blot analysis of transfected cell
lysates revealed comparable expression levels of the Myc-
tagged proteins, PKD(63kD), PDK(58kD) and
PDK(R474A), in these experiments (Figure 4b; if any-
thing, PDK(R474A) was expressed at a higher level), sug-
gesting that the inhibition of PDK-1’s ability to
potentiate PDGF-stimulated PKB activity by the PH-
domain mutation R474A was not a result of reduced
Figure 4
Effects of PDK-1 co-expression on PKB activity in PAE cells. (a) PAE
cells were cotransfected with 20 µg of the PKB(S473D) vector and
either 3 µg of the PDK(58kD), PDK(63kD) or PDK(R474A) vector, or
an irrelevant DNA. Transfected cells were incubated for 12 h, then
serum starved for 11 h. Where appropriate, cells were stimulated for
45 sec with 2 ng/ml PDGF-BB (grey bars). The activity of PKB
(arbitrary units) in anti-EE immunoprecipitates prepared from lysates of
the transfected cells was assessed using myelin basic protein as a
substrate. The non-specific kinase activity of the immunoprecipitates
was subtracted as background. The data presented are the
mean ± SEM for n ≥ 8 from at least four independent experiments.
(b) Immunoblot results illustrating expression levels of PDK(58kD)
(lane 1), PDK(63kD) (lane 2) and PDK(R474A) (lane 3) in transfected
cells. Equal numbers of cells from each transfection were solubilised in
SDS sample buffer, subjected to SDS–PAGE, transferred to
nitrocellulose and probed with an anti-Myc monoclonal antibody
(9E10) as described in Materials and methods.
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Wortmannin inhibits the effects of PDK(63kD) and PDK(R424A)
expression on PKB activity. PAE cells were cotransfected with
PKB(S473D) and either PDK(63kD) or PDK(R474A) plasmids and
treated as described for Figure 4. Where indicated, cells were
pretreated with 100 nM wortmannin for 90 min prior to a 45 sec
stimulation with 2 ng/ml PDGF-BB (grey bars). The activity of
ectopically expressed EE-tagged PKB was assessed as described for
Figure 4. The data presented are the mean ± SEM for n ≥ 4 from at























expression levels. The fact that PDK(R474A) failed both
to translocate to the plasma membrane and to support
activation of PKB in response to PDGF indicates the
importance of plasma membrane localisation of PDK-1
for its activation of PKB.
Membrane targeting of PDK-1 produces a constitutively
active protein
To further investigate the relationship between plasma
membrane localisation of PDK-1 and its ability to amplify
the PDGF-stimulated PKB activity, both 63 kDa PDK-1
and its R474A variant were modified by the addition of a
myristoylation/palmitoylation sequence to the amino-ter-
minal end and a Myc tag to the carboxy-terminal end
(giving myrPDK(63kD) and myrPDK(R474A), respec-
tively). Both constructs expressed well and showed clear
plasma membrane localisation in unstimulated cells, with
some cells displaying additional nuclear staining
(Figure 6). Expression of myrPDK(63kD) led to the consti-
tutive activation of co-expressed PKB(S473D) in cell
lysates prepared from unstimulated cells and, under the
conditions studied, this PKB activation did not increase
further when cells were stimulated with PDGF (Figure 7).
The effect of myristoylation on PDK-1 was sensitive to
inhibition by wortmannin (data not shown), suggesting that
at some level PtdIns(3,4,5)P3 must bind to PKB to promote
its phosphorylation by PDK-1. In marked contrast to non-
membrane-targeted PDK(R474A), myristoylation of the
PH-domain mutant of PDK-1 induced a high level of PKB
activation, comparable to that induced by wild-type
myrPDK(63kD), under both unstimulated and stimulated
conditions (Figure 7). This ability of myrPDK(R474A) to
activate co-expressed PKB indicated that the point muta-
tion of Arg474 in the PH domain of PDK-1 did not affect
the ability of the enzyme to phosphorylate and activate
PKB. Western blot analysis showed that both
myrPDK(63kD) and myrPDK(R474A) were expressed at
lower levels than the non-myristoylated constructs
(although differential detection of carboxy-terminal and
amino-terminal Myc tags cannot be excluded). Expression
levels of myrPDK(63kD) and myrPDK(R474A) were com-
parable, however, (data not shown).
To confirm the role of the PH domain in PDK-1’s translo-
cation, a plasmid was generated that would drive produc-
tion of a Myc-tagged form of the PH domain of PDK-1
(residues 411–556 of the 63 kDa form) in PAE cells.
Immunolocalisation of this construct in unstimulated cells
revealed nuclear staining — suggesting that a nuclear
localisation sequence might have been unmasked with
removal of the first 410 amino acids or that, given the
small size of the isolated PH domain, it might accumulate
in the nucleus by diffusion — and significantly less
cytosolic staining than for the 63 kDa form of PDK-1 (data
not shown). PDGF stimulation of the cells resulted in
reduced nuclear staining and additional homogenous
staining across the cell (data not shown), suggesting that
the PH domain of PDK-1 could, in isolation, translocate to
the plasma membrane in response to PDGF. Further-
more, translocation of the isolated PH domain was inhib-
ited by wortmannin (data not shown) and, hence, is likely
to be dependent on PI 3-kinase.
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Figure 7
Effect of membrane targeting of 63 kDa PDK-1 and 63 kDa R474A
PDK-1 on PKB activity. PAE cells were cotransfected with the vector
for PKB(S473D) and either plasmids encoding the indicated
constructs or an irrelevant DNA. Cells were treated, and the 
EE-associated PKB activity quantitated as described for Figure 4. 
























Effect of myristoylation on cellular localisation of 63 kDa PDK-1 and
63 kDa R424A PDK-1. PAE cells were transiently transfected with
20 µg of the plasmids encoding the indicated constructs, grown and
processed for immunohistochemistry as described for Figure 1, using
the anti-Myc monoclonal antibody 9E10 as a primary antibody and
FITC-conjugated goat anti-mouse as a secondary antibody.
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Discussion
Our results clearly show that PDGF stimulates a substan-
tial translocation of ectopically expressed PDK-1 from the
cytosol to the plasma membrane in PAE cells. This
translocation is dependent upon PDGF-stimulated PI
3-kinase activity and requires an intact PDK-1 PH
domain. These findings are consistent with our previous
data describing the translocation of purified PDK-1 to arti-
ficial lipid vesicles containing low molar ratios of
PtdIns(3,4,5)P3 and PtdIns(3,4)P2 in vitro [18], and thus
support a model in which the lipid products of PI 3-kinase
affect the ‘activity’ of PDK-1 in some way.
Co-expression of PDK-1 with PKB(S473D) significantly
elevates the activity of ectopically expressed PKB in
unstimulated cells. It is possible that resting cells contain
sufficient levels of the lipid products of PI 3-kinase in the
membrane to provide a certain degree of membrane tar-
geting of PDK-1. Co-expression of PDK-1 also substan-
tially elevates PKB(S473D) activity during a 45 second
stimulation with PDGF. We have recently used similar
results to argue that PDK-1 is used by growth factor recep-
tors as a primary mechanism for activating PKB [18]. Our
results here show that PDK-1 with a defective PH
domain, which cannot translocate to the plasma mem-
brane in response to PDGF, cannot support this increased
activation of PKB. This indicates that translocation to the
plasma membrane is important for the ability of PDK-1 to
phosphorylate and activate PKB. This conclusion is sup-
ported by our results showing that PDK-1 artificially tar-
geted to the plasma membrane is constitutively active
with respect to its ability to activate PKB. 
How might translocation of PDK-1 and its substrate PKB
to the plasma membrane lead to increased phosphoryla-
tion and activation of PKB? In principle, the mechanism
could involve either a substrate ‘concentrating’ effect,
some change to PKB that facilitates phosphorylation of
Thr308, or an increase in the intrinsic catalytic activity of
PDK-1. The latter mechanism appears unlikely in view of
the recent evidence suggesting that PDK-1’s ability to
phosphorylate a soluble target, p70S6K, is not regulated by
PtdIns(3,4,5)P3 [20,21]. The observation that the ability of
PDK(R474A) to activate PKB in unstimulated cells is sen-
sitive to wortmannin is evidence in favour of an effect of
PtdIns(3,4,5)P3 on PKB beyond membrane targeting. This
issue requires further investigation in some form of
defined in vitro system before it can be fully resolved,
however, using mutants of PKB and PDK-1 that are
membrane localised independently of PtdIns(3,4,5)P3
binding. It must be appreciated that ectopic expression of
PDK-1 and PKB might distort the relative requirements
for translocation of these proteins from the situation that
exists in normal cells; for example, given the high affinity
of PDK-1 for PtdIns(3,4,5)P3 in vitro, it is possible that in
some circumstances the basal levels of PtdIns(3,4,5)P3 are
sufficient to localise significant quantities of PDK-1 to
make its translocation essentially ‘constitutive’.
The observation that translocation of PDK-1 to the plasma
membrane is important for its ability to phosphorylate
Thr308 in PKB has some interesting implications for the
role of PDK-1 in phosphorylating other potential down-
stream targets. It has been suggested that PDK-1 might
act to phosphorylate conserved sites in the kinase activa-
tion loop of a subfamily of protein kinases [24], and this
idea has received support from the observation that
PDK-1 can phosphorylate the analogous Thr252 residue
in p70S6K [20,21]. It has been shown that p70S6K, which is
found in the nucleus and cytosol of resting cells, can
translocate into the nucleus in response to some stimuli
[25], but there is no evidence that it can translocate to the
plasma membrane upon growth factor stimulation. It will
be of great interest, therefore, to investigate what effect
targeting of PDK-1 to the plasma membrane has on its
ability to phosphorylate p70S6K.
This study strengthens the emerging concept that certain
PH domains can act as specific membrane recruitment
modules controlling the translocation of soluble protein to
the part of the membrane in which PtdIns(3,4,5)P3 and
PtdIns(3,4)P2 are synthesised. It seems likely, however,
that this translocation, for any particular protein, is not the
sole factor determining its regulation but that other factors
are important — for example, PKB activation requires that
at least one additional protein kinase, PDK-1, is also
translocated to the membrane.
Materials and methods
PDK-1 constructs
The cDNA encoding either 58 kDa or 63 kDa PDK-1 (which have the
amino acid sequences MDGTAAE… and MARTTSQ…, respectively,
in single-letter code, at their amino termini) or a catalytically inactive
splice variant [18] were ligated in frame with an amino-terminal Myc
(MEQKLISEEDLEF) tag into the pCMV3 transient expression vector
[26]. Point mutation (R474A) of the PH domain of 63 kDa PDK-1 was
generated by a PCR-based mutagenic strategy using Pfu polymerase
(Stratagene). For membrane-targeting experiments, carboxy-terminal
Myc tags were generated on 63 kDa PDK-1 and R474A PDK-1 and
the constructs were ligated into a pCMV3 expression vector contain-
ing an amino-terminal myristoylation/palmitoylation sequence from the
Yes Src-type kinase (MGLCIKSKEDKSM) [27]. Residues 411–556
of PDK(63kD) were placed in frame with an amino-terminal Myc tag in
the pCMV3 transient expression vector to construct an isolated 
PDK-1 PH domain. For construction of an active PI 3-kinase allele,
and a kinase-dead R947P derivative, the cDNA encoding pig 110γ
[26] was ligated into the same amino-terminal myristoylation/palmitoy-
lation vector (a gift from Alicia Eguinoa). All constructs were verified
by sequencing.
Cell culture
PAE cells expressing the PDGF receptor were grown in F12 nutrient
mixture (Ham F12; Gibco BRL) containing 10% heat-inactivated fetal
bovine serum (HI-FBS) at 37°C in a 6% CO2 humidified atmosphere.
Cos-7 cells were maintained in Dulbecco’s modified Eagle Medium
(DMEM; Gibco BRL) containing 10% HI-FBS at 37°C in a 6% CO2
humidified atmosphere.
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Transient transfection
PAE cells (1 × 107) were transfected by electroporation as described
previously [13,18]. Transfected cells were replated into 6 cm tissue
culture dishes (2 × 106 cells per dish) for PKB kinase assays, or onto
glass coverslips (8 × 104 cells per coverslip) for immunofluorescence
experiments, in F12 containing 10% HI-FBS for 12 h (PKB assays) or
30 h (immunofluorescence) and then serum starved for 11 h (PKB
assays) or 15 h (immunofluorescence) in F12 containing 0.1% fatty-
acid-free BSA, in the presence of 1 U/ml penicillin and 0.1 mg/ml
streptomycin (see the figure legends). Confluent monolayers of Cos-7
cells were transfected with 20 µg DNA by the DEAE–dextran method
as previously described [28]. Cells were grown in DMEM containing
10% HI-FCS, penicillin and streptomycin for 20 h, trypsinised, diluted
1:50 and replated onto glass coverslips for a further 12 h, then serum
starved for 12 h in DMEM containing 0.1% fatty-acid-free BSA, peni-
cillin and streptomycin.
PKB assay
PKB assays were performed on transfected PAE cells essentially as
described previously [13] with the following modifications. When
required, cells were pretreated with 100 nM wortmannin for 90 min
(2 × 45 min) in F12 containing 0.1% fatty-acid-free BSA, penicillin and
streptomycin, prior to experiments. Cells were stimulated, when appro-
priate, with 2 ng/ml PDGF-BB for 45 sec. In a number of experiments,
expression levels of transfected PKB and PDK-1 constructs were com-
pared in parallel by western blotting. For this, the transfected cells were
grown and serum starved under the same conditions as those for the
PKB assay. Equal numbers of cells from each transfection were solu-
bilised in Laemmli SDS sample buffer and the proteins were separated
by 8% SDS–PAGE, transferred to nitrocellulose and blotted with an
anti-EE monoclonal antibody (to detect PKB) or anti-Myc monoclonal
antibody 9E10 (to detect PDK-1). Expression was visualised by the
standard enhanced chemiluminescence procedure. Autofluorograms
were densitometrically scanned with a BioRad Gel Doc 1000 system
and quantified with the BioRad Molecular Analyst program to estimate
the differences in expression levels.
Immunofluorescence microscopy
Cells for immunofluorescence microscopy were grown on glass cover-
slips and serum starved as described above. Where appropriate, cells
were pretreated with 100 nM wortmannin for 10 min then stimulated
with PDGF (10 ng/ml) for 5 min at 37°C. Activation was terminated by
aspirating the medium and fixing cells with the immediate addition of
4% paraformaldehyde in 100 mM Pipes (pH 7.2), 2 mM EGTA, 2 mM
MgCl2 for 15 min at room temperature (RT). The cells were washed
three times in 150 mM Tris, pH 7.2, permeabilised for 10 min at RT in
PBS, 0.1% Triton X-100 and then washed twice in PBS. Coverslips
were blocked with PBS, 0.5% BSA for 20 min at RT and then incu-
bated with an anti-Myc monoclonal antibody (9E10; 1:2) for 1 h at RT.
The coverslips were washed 3 × 5 min in PBS, 0.5% BSA and then
incubated with the secondary FITC-conjugated goat anti-mouse anti-
body (1:100; Sigma). Coverslips were washed for 3 × 5 min in PBS,
0.5% BSA, 5 min in PBS and then in H2O before being mounted onto
microscope slides with Aqua-polymount anti-fading solution (Poly-
Sciences Inc.). Confocal imaging was performed using a NORAN Oz
confocal microscope (NORAN Instruments) and a confocal z-section
depth of < 1 µm.
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